Loading
Latest filing published 30 Jun 2026 for SCYNEXIS INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Guy Macdonald span 2 companies, the busiest being Tetraphase Pharmaceuticals Inc and Scynexis Inc. In total, 64 filings cover trades dated from 10 February 2014 to 26 June 2026.
On the open market, the record shows 2 purchases worth €125k and 24 sales worth €7.2M. Sales outweigh purchases by €7.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 10 share grants and 27 option exercises.
The latest filing, published on 30 June 2026, reports a share grant in Scynexis Inc. The last purchase on record was published on 23 December 2020, which is 2,130 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations